Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001140361-22-012058
Filing Date
2022-03-31
Accepted
2022-03-31 07:46:31
Documents
81
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 10-K brhc10035119_10k.htm   iXBRL 10-K 1841672
2 EXHIBIT 21.1 brhc10035119_ex21-1.htm EX-21.1 4494
3 EXHIBIT 23.1 brhc10035119_ex23-1.htm EX-23.1 3653
4 EXHIBIT 31.1 brhc10035119_ex31-1.htm EX-31.1 19558
5 EXHIBIT 31.2 brhc10035119_ex31-2.htm EX-31.2 19515
6 EXHIBIT 32.1 brhc10035119_ex32-1.htm EX-32.1 8851
7 EXHIBIT 32.2 brhc10035119_ex32-2.htm EX-32.2 8851
  Complete submission text file 0001140361-22-012058.txt   8265523

Data Files

Seq Description Document Type Size
8 XBRL TAXONOMY EXTENSION SCHEMA galt-20211231.xsd EX-101.SCH 67397
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE galt-20211231_cal.xml EX-101.CAL 42059
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE galt-20211231_def.xml EX-101.DEF 348627
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE galt-20211231_lab.xml EX-101.LAB 852733
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE galt-20211231_pre.xml EX-101.PRE 539488
75 EXTRACTED XBRL INSTANCE DOCUMENT brhc10035119_10k_htm.xml XML 1084838
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Filer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-31791 | Film No.: 22789153
SIC: 2834 Pharmaceutical Preparations